It was a conversion of performance rights - the recent price rise must have triggered conversion. Basically the director got them for free
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025